Home RxNorm 1660937 60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1660937
RxNorm name 60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler
Display name Formoterol/Mometasone (Inhalant)
Full name 60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler
Term type SCD
Status Active
Strength 5-200 mcg/puff
Dose form MDI 60 puff
Route Inhalant
Updated 2026-10-20 20:49:44 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 092015
Active start 092015
Multiple ingredient YES
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength mometasone furoate 200 MCG / 1 ACTUAT mometasone mometasone furoate formoterol fumarate 5 MCG / 1 ACTUAT formoterol formoterol fumarate
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Dulera MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE Organon LLC 8f399784-f257-4f31-b3dc-368bf2a1864d 2026-07-10 Warnings, Adverse reactions Exact identifier rxcui: 1660937
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 8f399784-f257-4f31-b3dc-368bf2a1864d mometasone furoate/formoterol fumarate 200/5 MCG/INHAL Metered Dose Inhaler, 60 Actuations [PSN] · 60 ACTUAT formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler [SCD] · formoterol fumarate 0.005 MG / mometasone furoate 0.2 MG per ACTUAT Metered Dose Inhaler, 60 ACTUAT [SY] · formoterol fumarate 5 MCG / mometasone furoate 200 MCG per ACTUAT Metered Dose Inhaler, 60 ACTUAT [SY] 4 7 These highlights do not include all the information needed to use DULERA safely and effectively. See full prescribing information for DULERA. DULERA ® (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2010 20260130
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics ATC1-4 formoterol / mometasone ATC R01AD Corticosteroids ATC1-4 mometasone ATC D07AC Corticosteroids, potent (group III) ATC1-4 mometasone ATC D07XC Corticosteroids, potent, other combinations ATC1-4 mometasone ATC R03BA Glucocorticoids ATC1-4 mometasone ATC R03CC Selective beta-2-adrenoreceptor agonists ATC1-4 formoterol ATC R03AC Selective beta-2-adrenoreceptor agonists ATC1-4 formoterol FDASPL N0000175779 beta2-Adrenergic Agonist EPC has_epc formoterol FDASPL N0000175576 Corticosteroid EPC has_epc mometasone FDASPL N0000009922 Adrenergic beta2-Agonists MOA has_moa formoterol FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa mometasone MEDRT D000068759 Formoterol Fumarate CHEM has_ingredient formoterol MEDRT D000068759 Formoterol Fumarate CHEM has_ingredient formoterol fumarate MEDRT D000068656 Mometasone Furoate CHEM has_ingredient mometasone MEDRT D000068656 Mometasone Furoate CHEM has_ingredient mometasone furoate MEDRT D000208 Acute Disease DISEASE ci_with formoterol MEDRT D000208 Acute Disease DISEASE ci_with formoterol fumarate MEDRT D001249 Asthma DISEASE ci_with formoterol MEDRT D001249 Asthma DISEASE may_treat formoterol MEDRT D001249 Asthma DISEASE may_treat formoterol fumarate MEDRT D001249 Asthma DISEASE ci_with formoterol fumarate MEDRT D001250 Asthma, Exercise-Induced DISEASE may_prevent formoterol MEDRT D001250 Asthma, Exercise-Induced DISEASE may_prevent formoterol fumarate MEDRT D001986 Bronchial Spasm DISEASE may_treat formoterol MEDRT D001986 Bronchial Spasm DISEASE may_prevent formoterol MEDRT D001986 Bronchial Spasm DISEASE may_treat formoterol fumarate MEDRT D001986 Bronchial Spasm DISEASE may_prevent formoterol fumarate MEDRT D003881 Dermatomycoses DISEASE ci_with mometasone furoate MEDRT D003881 Dermatomycoses DISEASE ci_with mometasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with mometasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with mometasone furoate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with formoterol fumarate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with formoterol MEDRT D005148 Facial Dermatoses DISEASE may_treat mometasone MEDRT D005148 Facial Dermatoses DISEASE may_treat mometasone furoate MEDRT D005533 Foot Dermatoses DISEASE may_treat mometasone furoate MEDRT D005533 Foot Dermatoses DISEASE may_treat mometasone MEDRT D006229 Hand Dermatoses DISEASE may_treat mometasone MEDRT D006229 Hand Dermatoses DISEASE may_treat mometasone furoate MEDRT D006561 Herpes Simplex DISEASE ci_with mometasone furoate MEDRT D006561 Herpes Simplex DISEASE ci_with mometasone MEDRT D006562 Herpes Zoster DISEASE ci_with mometasone furoate MEDRT D006562 Herpes Zoster DISEASE ci_with mometasone MEDRT D006967 Hypersensitivity DISEASE ci_with mometasone furoate MEDRT D007249 Inflammation DISEASE may_treat mometasone MEDRT D007249 Inflammation DISEASE may_treat mometasone furoate MEDRT D007868 Leg Dermatoses DISEASE may_treat mometasone MEDRT D007868 Leg Dermatoses DISEASE may_treat mometasone furoate MEDRT D011537 Pruritus DISEASE may_treat mometasone MEDRT D011537 Pruritus DISEASE may_treat mometasone furoate MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat mometasone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat mometasone furoate MEDRT D012536 Scalp Dermatoses DISEASE may_treat mometasone furoate MEDRT D012536 Scalp Dermatoses DISEASE may_treat mometasone MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with mometasone MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with mometasone furoate MEDRT N0000009922 Adrenergic beta2-Agonists MOA has_moa formoterol fumarate MEDRT N0000009922 Adrenergic beta2-Agonists MOA has_moa formoterol MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa mometasone furoate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa mometasone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa mometasone furoate MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa mometasone MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa formoterol MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa formoterol fumarate MEDRT N0000008322 Bronchodilation PE has_pe formoterol MEDRT N0000008322 Bronchodilation PE has_pe formoterol fumarate MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe mometasone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe mometasone furoate MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe mometasone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe mometasone furoate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe mometasone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe mometasone furoate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe mometasone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe mometasone furoate MEDRT N0000009908 Vasoconstriction PE has_pe mometasone MEDRT N0000009908 Vasoconstriction PE has_pe mometasone furoate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.005 MG/ACTUAT (expressed as formoterol fumarate) / 0.2 MG/ACTUAT (expressed as mometasone furoate) ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 60 ACTUAT ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4038520 NAMES Prescribable Synonym mometasone furoate/formoterol fumarate 200/5 MCG/INHAL Metered Dose Inhaler, 60 Actuations SOURCES Source Veterans Health Administration National Drug File